A detailed history of Ikarian Capital, LLC transactions in Achilles Therapeutics PLC stock. As of the latest transaction made, Ikarian Capital, LLC holds 1,443,181 shares of ACHL stock, worth $1.41 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
1,443,181
Previous 1,443,181 -0.0%
Holding current value
$1.41 Million
Previous $1.18 Million 24.43%
% of portfolio
0.26%
Previous 0.48%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$0.82 - $1.57 $1.18 Million - $2.27 Million
1,443,181 New
1,443,181 $1.8 Million

Others Institutions Holding ACHL

About Achilles Therapeutics plc


  • Ticker ACHL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,774,000
  • Market Cap $40M
  • Description
  • Achilles Therapeutics Plc, a clinical stage immuno-oncology biopharmaceutical company, develops precision T cell therapies to treat various solid tumors. The company's lead product candidates include CHIRON, which is in Phase I/IIa clinical trial for use in the treatment of advanced non-small cell lung cancer; and THETIS, a product candidate in ...
More about ACHL
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.